Aurinia Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.0M | 541k | 11.05 |
| 2025-06-30 | $5.5M | 650k | 8.47 |
| 2025-03-31 | $6.0M | 746k | 8.04 |
| 2024-12-31 | $5.0M | 557k | 8.98 |
| 2024-09-30 | $3.3M | 454k | 7.33 |
| 2021-06-30 | $4.8M | 367k | 12.96 |
| 2021-03-31 | $5.7M | 436k | 13.00 |
| 2020-12-31 | $28M | 2.0M | 13.79 |
| 2020-09-30 | $24M | 1.6M | 14.72 |
| 2020-06-30 | $24M | 1.5M | 16.24 |
| 2020-03-31 | $16M | 1.1M | 14.53 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management